News About: Pharm. Industry
Bae named to head Sanofi-Aventis KoreaFrench drugmaker Sanofi said Monday it has appointed Bae Kyung-eun, CEO of Genzyme Korea, to replace Jean-Marie Arnaud, general manager of Sanofi-Aventis Korea, who will become ...
|
Innovative drug firms set up three sub-committees
The consultative body for 42 innovative drug firms, which belongs to the Korea Pharmaceutical Manufacturers Association (KPMA), held its first meeting last Friday to launch its three sub-committees named “Innovative R...
Sanofi-Aventis Korea gains KDRA membership
Recently, Sanofi-Aventis Korea, a local unit of Paris-based leading health care company, joined the Korea Drug Research Association (KDRA) as one of the full-fledged members.
The KDRA, established in August 1986, c...
Local drugmakers urged to regain public credibility
The local pharmaceutical industry came under fire as Wales Korea Pharm was found to have forged the shelf life of its drug.
The Ministry of Food and Drug Safety (MFDS) announced recently that it ordered Wales Korea...
Binex to export Remicade biosimilar to Russia
Binex said Thursday it will export Remicade biosimilar to Pharmstandard, Russia’s leading drugmaker.
Developed by Johnson & Johnson, Remicade is a blockbuster rheumatoid arthritis drug.
The Korean pharmaceutical...
Korean drug makers blast KRPIA’s plan to change name
Korean drug firms strongly protested the Korean Research-based Pharmaceutical Industry Association (KRPIA) renewing its plan to change its name.
The KRPIA is considering changing its Korean name by deleting “multin...
Karolinska Institutet seeks partnership with Kael Gemvax over GV1001
Sweden based Karolinska Institutet, one of Europe's largest and most prestigious medical universities, sent out a letter of intent (LOI) to Kael Gemvax to jointly conduct Phase II clinical trial of GV 1001, Kael Gemva...
Boryung receives approval for additional Indication of Stogar tablets
Boryung Pharmaceutical Co. announced today that it has received approval from the Ministry of Food and Drug Safety for gastro-esophagegus reflux disease (GERD) as an additional indication of Stogar (lafutidine) tablet...
Handok teams up with Osong Medical Foundation to develop new drugs
Handok Pharmaceutical will strengthen its new drug development business through a partnership with the Osong Medical Industry Promotion Foundation (OMIPF).
On Monday, the chairman of Handok and OMIPF chief announce...
Polarization deepens in drug industry
Gone are the times when mid- and small-sized drug firms earned profits easily by producing generics, which refer to drugs that have the same ingredients and effects as the original brand name drugs. They are now on th...
